Amalgamated Bank Novo Cure LTD Transaction History

Amalgamated Bank

$11.7 Billion
Q1 2025

A detailed history of Amalgamated Bank transactions in Novo Cure LTD stock. As of the latest transaction made, Amalgamated Bank holds 3,729 shares of NVCR stock, worth $68,539. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,729

Previous 3,716 0.35%

Holding current value

$68,539

Previous $111,000 40.54%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	BUY	$17.82 - $30.19 $231 - $392	13 Added 0.35%	3,729 $66,000
Q2 2024 Aug 12, 2024	SELL	$11.83 - $24.05 $37,536 - $76,310	-3,173 Reduced 46.06%	3,716 $64,000
Q1 2024 Apr 23, 2024	SELL	$12.42 - $17.29 $176,041 - $245,068	-14,174 Reduced 67.29%	6,889 $108,000
Q4 2023 Feb 06, 2024	SELL	$11.13 - $15.78 $30,985 - $43,931	-2,784 Reduced 11.67%	21,063 $314,000
Q3 2023 Nov 08, 2023	BUY	$16.15 - $42.35 $17,312 - $45,399	1,072 Added 4.71%	23,847 $385,000
Q2 2023 Aug 11, 2023	BUY	$40.29 - $82.51 $45,205 - $92,576	1,122 Added 5.18%	22,775 $945,000
Q1 2023 May 02, 2023	SELL	$56.44 - $118.81 $120,555 - $253,778	-2,136 Reduced 8.98%	21,653 $1.3 Million
Q4 2022 Feb 10, 2023	BUY	$63.98 - $85.37 $9,916 - $13,232	155 Added 0.66%	23,789 $1.75 Million
Q3 2022 Nov 09, 2022	BUY	$67.99 - $89.57 $27,060 - $35,648	398 Added 1.71%	23,634 $1.8 Million
Q2 2022 Aug 15, 2022	BUY	$56.6 - $89.9 $661,031 - $1.05 Million	11,679 Added 101.06%	23,236 $1.62 Million
Q1 2022 Aug 25, 2022	BUY	$60.15 - $84.52 $695,153 - $976,797	11,557 New	11,557 $957,000
Q4 2020 Feb 12, 2021	SELL	$112.16 - $174.14 $2.25 Million - $3.5 Million	-20,102 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$58.05 - $111.31 $29,779 - $57,102	-513 Reduced 2.49%	20,102 $2.24 Million
Q2 2020 Aug 10, 2020	BUY	$57.2 - $74.41 $300,986 - $391,545	5,262 Added 34.27%	20,615 $1.22 Million
Q1 2020 May 13, 2020	SELL	$57.05 - $95.75 $29,152 - $48,928	-511 Reduced 3.22%	15,353 $1.03 Million
Q4 2019 Feb 13, 2020	BUY	$68.3 - $93.8 $58,942 - $80,949	863 Added 5.75%	15,864 $1.34 Million
Q3 2019 Nov 13, 2019	SELL	$61.86 - $97.8 $11,753 - $18,582	-190 Reduced 1.25%	15,001 $1.12 Million
Q2 2019 Aug 14, 2019	BUY	$42.22 - $63.23 $170,442 - $255,259	4,037 Added 36.19%	15,191 $961,000
Q1 2019 May 15, 2019	BUY	$31.96 - $56.12 $14,382 - $25,254	450 Added 4.2%	11,154 $537,000
Q4 2018 Feb 15, 2019	BUY	$28.72 - $52.63 $183,635 - $336,516	6,394 Added 148.35%	10,704 $358,000
Q3 2018 Nov 14, 2018	SELL	$32.0 - $52.4 $212,736 - $348,355	-6,648 Reduced 60.67%	4,310 $226,000
Q2 2018 Jul 18, 2018	BUY	$19.85 - $32.0 $217,516 - $350,656	10,958 New	10,958 $343,000

Others Institutions Holding NVCR

# of Institutions

266

Shares Held

79.4M

Call Options Held

970K

Put Options Held

118K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.93B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Novo Cure LTD Transaction History